Document is current
Any future updates will be listed below
-
Authors
Erngren, Ida
Vaivade, Aina
Carlsson, Henrik
Al-Grety, Asma
Åkerfeldt, Torbjörn
Kockum, Ingrid
Hedström, Anna Karin
Alfredsson, Lars
Olsson, Tomas
Burman, Joachim
Kultima, Kim
-
Funding
Funding for this research was provided by:
FORTE (2024-01410)
Swedish Foundation for MS Research
NEURO Sweden
Magnus Bergvalls Stiftelse
Stiftelsen Lars Hiertas Minne
Vetenskapsrådet (2021–02814)
Vetenskapsrådet (2021-02189)
Svenska Läkaresällskapet (SLS-59352)
Svenska Sällskapet för Medicinsk Forskning
Marianne and Marcus Wallenberg Foundation
Svenska Forskningsrådet Formas (2020-01267)
Region Uppsala
Åke Wiberg Stiftelse
Uppsala University
- License Information
-
More Information
Article History
Received: 28 November 2024
Accepted: 27 March 2025
First Online: 9 April 2025
Declarations
:
: Sample collection and storage complied with local ethical standards and applicable national laws regarding human studies. The corresponding ethical approvals are EPN Uppsala: 2021–00702; EPN Stockholm: 04–252/1–4 and 2017/2386–32. All participants provided written informed consent.
: Not applicable, as no identifiable human data or images are included in this manuscript.
: TO has received lecture/advisory board honoraria from Biogen, Novartis, Merck, and Sanofi and unrestricted MS research grants from the same companies. LA has received honoraria for lectures Biogen, Merck, and Teva. IK has received collaborative research support from Neurogene INC in an unrelated project and speaker’s honorary from Merck.
